PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Interview: X4 Pharmaceuticals’ Paula Ragan Shares Insights on Mavorixafor for the Treatment of Multiple Immunodeficiencies

PharmaShots Interview: X4 Pharmaceuticals’ Paula Ragan Shares Insights on Mavorixafor for the Treatment of Multiple Immunodeficien...

May 3, 2022

$Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer$

Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer

May 3, 2022

Genesis Entered into a Collaboration with Lilly to Discover Novel Therapies for up to Five Targets

Genesis Entered into a Collaboration with Lilly to Discover Novel Therapies for up to Five Targets

May 3, 2022

Denali Partner Sanofi Reports the Patient Dosing in P-II (HIMALAYA) Study of SAR443820 for the Treatment of Amyotrophic Lateral Sclerosis

Denali Partner Sanofi Reports the Patient Dosing in P-II (HIMALAYA) Study of SAR443820 for the Treatment of Amyotrophic Lateral Sc...

May 3, 2022

Apellis Presents 18-Month Results of Pegcetacoplan in P-III (DERBY) and (OAKS) Studies for the Treatment of Geographic Atrophy at ARVO 2022

Apellis Presents 18-Month Results of Pegcetacoplan in P-III (DERBY) and (OAKS) Studies for the Treatment of Geographic Atrophy at...

May 3, 2022

UCB Publishes Results of Fintepla (fenfluramine) in the P-III Trial for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome in JAMA Neurology

UCB Publishes Results of Fintepla (fenfluramine) in the P-III Trial for the Treatment of Seizures Associated with Lennox-Gastaut S...

May 3, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us